Journals / Anadolu Kardiyoloji Dergisi / 2014 / Cilt: 14 - Sayı: 1

The relationship between gamma-glutamyltransferase and coronary collateral circulation in patients with chronic total occlusion

Pages
48–54
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The poor coronary collateral group had significantly higher levels of serum GGT compared to the good collateral group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the relation between blood gamma-glutamyltransferase (GGT) levels and coronary collateral circulation in patients with chronic total occlusion (CTO).
📊
Key Findings & Data:Coronary collaterals were graded from 0 to 3 according to the Rentrop method.
💡
Conclusion & Impact:Results: The poor coronary collateral group had significantly higher levels of serum GGT compared to the good collateral group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to evaluate the relation between blood gamma-glutamyltransferase (GGT) levels and coronary collateral circulation in patients with chronic total occlusion (CTO). Methods: Two hundred twenty-two patients with chronic stable coronary artery disease (CAD) and CTO were included in this cross-sectional, observational study. Coronary collaterals were graded from 0 to 3 according to the Rentrop method. Patients with grade 0-1 collateral develop- ment were regarded as poor collateral group (n=66) while patients with grade 2-3 collateral development were regarded as good collateral group (n=156). Statistical analysis was performed using independent samples t, Mann-Whitney U and Chi-square tests, logistic regression and receiver operator curve analysis. Results: The poor coronary collateral group had significantly higher levels of serum GGT compared to the good collateral group (p

🔖

Cite This Article

ŞAHİN, M., DEMİR, S., KALKAN, M. E., ÖZKAN, B., ALICI, G., ÇAKALAĞAOĞLU, K. C., YAZICIOĞLU, M. V., SARIKAYA, S., BİTEKER, M., TÜRKMEN, M. M. (2022). The relationship between gamma-glutamyltransferase and coronary collateral circulation in patients with chronic total occlusion. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 1, 48–54. https://ajindex.com/articles/436071

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Levin DC. Pathways and functional significance of the coronary collateral circulation. Circulation 1974
  2. [CrossRef] 2. Steiner S, Schueller PO, Schulze V, Strauer BE. Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 2010
  3. [CrossRef] 3. Hirai T, Fujita M, Sasayama S, Ohno A, Yamanishi K, Nakajima H, et al. Importance of coronary collateral circulation for kinetics of serum creatine kinase in acute myocardial infarction. Am J Cardiol 1987
  4. [CrossRef] 4. Kodama K, Kusuoka H, Sakai A, Adachi T, Hasegawa S, Ueda Y, et al. Collateral channels that develop after an acute myocardial infarction prevent subsequent left ventricular dilation. J Am Coll Cardiol 1996
  5. [CrossRef] 5. Koerselman J, van der Graaf Y, de Jaegere PP Grobbee DE. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 2003
  6. [CrossRef] 6. Sherman JA, Hall A, Malenka DJ, De Muinck ED, Simons M. Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol 2006
  7. [CrossRef] 7. Werner GS, Jandt E, Krack A, Schwarz G, Mutschke O, Kuethe F, et al. Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation 2004
  8. [CrossRef] 8. Bozbaş H, Yıldırır A, Karaçağlar E, Demir O, Ulus T, Eroğlu S, et al. Increased serum gamma-glutamyltransferase activity in patients with metabolic syndrome. Turk Kardiyol Dern Ars 2011
  9. [CrossRef] 9. Corti A, Franzini M, Cianchetti S, Bergamini G, Lorenzini E, Melotti P et al. Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum. PLoS One 2012
  10. e34772 [CrossRef] 10. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gamma-glutamyltransferase and diabetes--a 4 year follow-up study. Diabetologia 2003
  11. Costa-Hong V, Bortolotto LA, Jorgetti V, Consolim-Colombo F, Krieger EM, Lima JJ. Oxidative stress and endothelial dysfunction in chronic kidney disease. Arq Bras Cardiol 2009
  12. Ulus T, Yıldırır A, Demirtaş S, Demir O, Sade LE, Bozbaş H, et al. Serum gamma-glutamyl transferase activity: a new marker for stent restenosis? Atherosclerosis 2007
  13. [CrossRef] 13. Demir B, Temizhan A, Keskin G, Baser K, Turak O, Çay S. Comparison of serum gamma-glutamyltran